4Filing Date: Aug 28, 2026

Intercontinental Exchange (ICE)

Statement of Changes in Beneficial Ownership

View SEC Filing
ACC: 0001193125-26-374604
Total Value$858.3K
Trades4
Insiders1

Transaction Details

Surdykowski Andrew J
General Counsel·Direct
Sell · Dispose
Common Stock
Shares-3.97K
Price$161.67
Total Value$642.5K
Shares Owned After43.66K
Transaction DateAug 26, 2026
10b5-1
Footnotes ▸

This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of November 25, 2025. | The price range for the aggregate amount sold by the direct holder is $161.16 - $162.14. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

Surdykowski Andrew J
General Counsel·Direct
Sell · Dispose
Common Stock
Shares-600
Price$162.38
Total Value$97.4K
Shares Owned After43.06K
Transaction DateAug 26, 2026
10b5-1
Footnotes ▸

This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of November 25, 2025. | The price range for the aggregate amount sold by the direct holder is $162.16 - $162.95. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. | The common stock number referred in Table I is an aggregate number and represents 35,891 shares of common stock and 5,734 unvested restricted stock units ("RSUs"), and 1,440 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year. | The satisfaction of the 2024, 2025 and 2026 TSR PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the 2024, 2025 and 2026 three-year earnings before interest, taxes, depreciation, and amortization ("EBITDA") PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. | The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period.

Surdykowski Andrew J
General Counsel·Direct
Exercise · Acquire
Common Stock
Shares+2.06K
Price$57.31
Total Value$118.3K
Shares Owned After47.64K
Transaction DateAug 26, 2026
10b5-1
Footnotes ▸

This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of November 25, 2025. | Amount of securities beneficially owned includes 101 shares acquired under Intercontinental Exchange, Inc. Employee Stock Purchase Plan on June 30, 2026.

Surdykowski Andrew J
General Counsel·Direct
Exercise · Dispose
Employee Stock Option (right to buy) HoldingDerivative
Shares-2.06K
Price$0.00
Total Value$0
Shares Owned After2.06K
Transaction DateAug 26, 2026
Exercise Price$57.31
ExpiresJan 18, 2027
10b5-1
Footnotes ▸

These options are fully vested.

Post-Transaction Holdings

Surdykowski Andrew J · General Counsel
SecuritySharesChange
Common Stock43.66K-2.51K (-5.43%)
Employee Stock Option (right to buy) Holding2.06K-2.06K (-50.01%)
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-08-26 10b5-1 Pre-arranged Plan: Yes --- Issuer --- Name: Intercontinental Exchange, Inc. (ICE) CIK: 0001571949 --- Reporting Owner --- Name: Surdykowski Andrew J CIK: 0001755922 Role: Officer (General Counsel) --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-08-26 | Code: M (Exercise of derivative) Shares: +2,065 | Price: $57.31 Total Value: $118,345.15 Shares Owned After: 47,639 | Ownership: D (Direct) Footnotes: [F1] This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of November 25, 2025. [F2] Amount of securities beneficially owned includes 101 shares acquired under Intercontinental Exchange, Inc. Employee Stock Purchase Plan on June 30, 2026. [Transaction #2] Security: Common Stock Date: 2026-08-26 | Code: S (Open market sale) Shares: -3,974 | Price: $161.67 Total Value: $642,491.28 Shares Owned After: 43,665 | Ownership: D (Direct) Footnotes: [F1] This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of November 25, 2025. [F3] The price range for the aggregate amount sold by the direct holder is $161.16 - $162.14. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. [Transaction #3] Security: Common Stock Date: 2026-08-26 | Code: S (Open market sale) Shares: -600 | Price: $162.38 Total Value: $97,429.98 Shares Owned After: 43,065 | Ownership: D (Direct) Footnotes: [F1] This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of November 25, 2025. [F4] The price range for the aggregate amount sold by the direct holder is $162.16 - $162.95. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. [F5] The common stock number referred in Table I is an aggregate number and represents 35,891 shares of common stock and 5,734 unvested restricted stock units ("RSUs"), and 1,440 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year. [F6] The satisfaction of the 2024, 2025 and 2026 TSR PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the 2024, 2025 and 2026 three-year earnings before interest, taxes, depreciation, and amortization ("EBITDA") PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. [F7] The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period. --- Derivative Transactions --- [Transaction #1] Security: Employee Stock Option (right to buy) Holding Date: 2026-08-26 | Code: M (Exercise of derivative) Shares: -2,065 | Price: $0.00 Exercise Price: $57.31 Exercisable: N/A | Expires: 2027-01-18 Shares Owned After: 2,064 | Ownership: D (Direct) Footnotes: [F8] These options are fully vested. --- Footnotes (Complete Index) --- F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of November 25, 2025. F2: Amount of securities beneficially owned includes 101 shares acquired under Intercontinental Exchange, Inc. Employee Stock Purchase Plan on June 30, 2026. F3: The price range for the aggregate amount sold by the direct holder is $161.16 - $162.14. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F4: The price range for the aggregate amount sold by the direct holder is $162.16 - $162.95. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F5: The common stock number referred in Table I is an aggregate number and represents 35,891 shares of common stock and 5,734 unvested restricted stock units ("RSUs"), and 1,440 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year. F6: The satisfaction of the 2024, 2025 and 2026 TSR PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the 2024, 2025 and 2026 three-year earnings before interest, taxes, depreciation, and amortization ("EBITDA") PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. F7: The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period. F8: These options are fully vested. --- Signature --- /s/ /s/ Octavia N. Spencer, Attorney-in-fact (2026-08-28)

keid analysis is for reference only and does not constitute investment advice.